Kolmar BNH Co., Ltd. (200130.KQ)

KRW 13410.0

(-0.59%)

EBITDA Summary of Kolmar BNH Co., Ltd.

Kolmar BNH Co., Ltd.'s latest annual EBITDA in 2023 was 46.76 Billion KRW , down -38.61% from previous year.
Kolmar BNH Co., Ltd.'s latest quarterly EBITDA in 2024 Q1 was 13.96 Billion KRW , up 70.99% from previous quarter.
Kolmar BNH Co., Ltd. reported an annual EBITDA of 75.64 Billion KRW in 2022, down -26.75% from previous year.
Kolmar BNH Co., Ltd. reported an annual EBITDA of 103.16 Billion KRW in 2021, down -12.27% from previous year.
Kolmar BNH Co., Ltd. reported a quarterly EBITDA of 13.96 Billion KRW for 2024 Q1, up 70.99% from previous quarter.
Kolmar BNH Co., Ltd. reported a quarterly EBITDA of N/A for 2023 FY, down -38.61% from previous quarter.

Annual EBITDA Chart of Kolmar BNH Co., Ltd. (2023 - 2014)

Historical Annual EBITDA of Kolmar BNH Co., Ltd. (2023 - 2014)

Year	EBITDA	EBITDA Growth
2023	46.76 Billion KRW	-38.61%
2022	75.64 Billion KRW	-26.75%
2021	103.16 Billion KRW	-12.27%
2020	117.64 Billion KRW	48.41%
2019	79.28 Billion KRW	26.35%
2018	62.67 Billion KRW	20.07%
2017	62.69 Billion KRW	36.1%
2016	38.84 Billion KRW	5.59%
2015	36.32 Billion KRW	23387.23%
2014	409.48 Million KRW	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	12.51 Billion KRW	-2.13%
2024 Q1	13.96 Billion KRW	70.99%
2023 FY	- KRW	-38.61%
2023 Q1	13.71 Billion KRW	6.82%
2023 Q2	13.89 Billion KRW	1.34%
2023 Q3	10.84 Billion KRW	-21.95%
2023 Q4	7.91 Billion KRW	-27.06%
2022 FY	- KRW	-26.75%
2022 Q4	12.83 Billion KRW	52.49%
2022 Q3	8.41 Billion KRW	-65.61%
2022 Q2	24.47 Billion KRW	13.68%
2022 Q1	21.53 Billion KRW	-20.01%
2021 Q2	25.8 Billion KRW	-17.18%
2021 Q3	19.23 Billion KRW	-25.45%
2021 FY	- KRW	-12.27%
2021 Q1	31.15 Billion KRW	7.37%
2021 Q4	26.92 Billion KRW	39.96%
2020 FY	- KRW	48.41%
2020 Q4	29.01 Billion KRW	13.68%
2020 Q3	25.52 Billion KRW	-31.64%
2020 Q2	37.33 Billion KRW	44.86%
2020 Q1	25.77 Billion KRW	18.82%
2019 Q2	20.97 Billion KRW	17.64%
2019 Q1	17.83 Billion KRW	0.84%
2019 FY	- KRW	26.35%
2019 Q4	21.68 Billion KRW	15.46%
2019 Q3	18.78 Billion KRW	-10.45%
2018 Q2	14.75 Billion KRW	-4.86%
2018 Q1	15.51 Billion KRW	11.63%
2018 Q3	14.72 Billion KRW	-0.19%
2018 FY	- KRW	20.07%
2018 Q4	17.68 Billion KRW	20.07%
2017 FY	- KRW	36.1%
2017 Q2	12.89 Billion KRW	16.36%
2017 Q1	11.08 Billion KRW	21.31%
2017 Q4	13.89 Billion KRW	-3.02%
2017 Q3	14.32 Billion KRW	11.1%
2016 Q2	10.79 Billion KRW	8.39%
2016 FY	- KRW	5.59%
2016 Q4	9.13 Billion KRW	7.88%
2016 Q3	8.46 Billion KRW	-21.54%
2016 Q1	9.95 Billion KRW	21.44%
2015 Q4	8.2 Billion KRW	-21.83%
2015 Q3	10.49 Billion KRW	10.48%
2015 Q2	9.49 Billion KRW	16.65%
2015 Q1	8.14 Billion KRW	0.0%
2015 FY	- KRW	23387.23%
2014 FY	- KRW	0.0%

Peer EBITDA Comparison of Kolmar BNH Co., Ltd.

Name	EBITDA	EBITDA Difference
NeoPharm CO., LTD.	31.01 Billion KRW	-50.798%